Severity of Pre-existing Cerebral Small Vessel Disease is Associated with Outcome after Traumatic Brain Injury
Document Type
Poster AbstractPublication Date
2014-05-20Keywords
Nervous System DiseasesNeurology
Pathological Conditions, Signs and Symptoms
Translational Medical Research
Metadata
Show full item recordAbstract
Background and purpose: It is now well accepted that traumatic white matter injury constitutes a critical determinant of post-traumatic functional impairment. However, the contribution of pre-existing white matter rarefaction on outcome following traumatic brain injury (TBI) is unknown. Hence, we sought to determine whether the burden of pre-existing cerebral small vessel disease related white matter rarefaction (leukoaraiosis) is independently associated with outcome after TBI. Methods: We retrospectively analyzed consecutive, prospectively enrolled patients of ≥50 years (n=136) that were admitted to a single neurological-trauma intensive care unit. Supratentorial white matter hypoattenuation on head CT was graded on a 5-point scale (range 0-4) reflecting increasing severity of leukoaraiosis. Outcome was ascertained according to the modified Rankin Scale (mRS) and Glasgow outcome scale (GOS) via telephone interview at 3 and 12 months, respectively. Results: After adjustment for other factors, leukoaraiosis-severity was significantly associated with a poor outcome at 3 and 12 months as defined as mRS 3-6 and GOS 1-3, respectively. The independent association between leukoaraiosis and a poor outcome remained when the analysis was restricted to patients that survived to 3 months, had moderate-to-severe TBI (enrolment Glasgow Coma Scale [GCS] ≤12; p=0.001), or had mild TBI (GCS 13-15; p=0.002), respectively. Conclusion: We provide first evidence that pre-existing cerebral small vessel disease independently predicts a poor functional outcome after closed head TBI. This association is independent of other established outcome predictors such as age, comorbid state as well as intensive care unit complications and interventions. This knowledge may help improve prognostic accuracy, clinical management, and resource utilization.DOI
10.13028/asam-k907Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27960Notes
Abstract of poster presented at the 2014 UMass Center for Clinical and Translational Science Research Retreat, held on May 20, 2014 at the University of Massachusetts Medical School, Worcester, Mass.
Rights
Copyright the Author(s)Distribution License
http://creativecommons.org/licenses/by-nc-sa/3.0/ae974a485f413a2113503eed53cd6c53
10.13028/asam-k907

